According to the Global Burden of Disease Study, not a single country has successfully reversed adult obesity rates.
Not one.
And as obesity rises in adults, kids, and teens, we’re seeing more:
- Type 2 diabetes
- Heart disease
- Cancer
- Multiple chronic conditions
That part isn’t new.
What is new?
Strong evidence that obesity also increases the risk of severe infections — the kind that land you in the hospital.
The Big Study
Researchers analyzed multiple large population cohorts across countries.
They compared adults with:
- Healthy weight
- Class I obesity (BMI 30–34.9)
- Class II obesity (BMI 35–39.9)
- Class III obesity (BMI ≥40)
Then they looked at who developed severe, hospital-treated infections.
Here’s what they found:
| Weight Category | Risk of Severe Infection |
|---|---|
| Any obesity (BMI ≥30) | 1.7× higher |
| Class I obesity | 1.5× higher |
| Class II obesity | 2× higher |
| Class III obesity | Nearly 3× higher |
This pattern held true whether researchers used:
- BMI
- Waist circumference
- Waist-to-height ratio
Bigger adiposity → higher infection risk.
Full stop.
And It Wasn’t Just COVID
Yes, obesity raised the risk of severe COVID.
But this study went much broader.
Elevated risk showed up across:
- Viral infections
- Bacterial infections
- Skin and soft tissue infections
- Respiratory infections
- Many hospital-treated infections
And here’s the kicker:
The increased risk remained even after adjusting for:
- Age
- Smoking
- Income
- Physical activity
- Diabetes
- Metabolic syndrome
Meaning:
It’s not just because obesity travels with other diseases.
Obesity itself appears to independently raise infection severity risk.
Why Would Body Fat Affect Infections?
It’s not just about weight. It’s about what excess fat does biologically.
Obesity creates:
- Chronic low-grade inflammation
- Insulin resistance
- Elevated blood sugar
- Immune system dysfunction
Your immune cells don’t work as well.
Specifically:
- T-cells underperform
- Natural killer (NK) cells weaken
- Neutrophils don’t function optimally
- Mucus clearance is reduced
- Lymphatic flow slows
Add high blood sugar (which pathogens love), and you’ve got a friendlier environment for microbes.
It’s not just “more weight.”
It’s an immune system under strain.
The Global Impact Is… Big
When researchers applied their findings to global data, they estimated:
👉 9–11% of infection-related deaths worldwide may be attributable to adult obesity.
During COVID?
That number likely climbed to ~15%.
That means roughly 1 in 10 infection deaths globally could be linked to obesity.
That’s not a niche issue.
That’s a public health lever.
The GLP-1 Twist
Now here’s where it gets interesting.
In the SELECT trial, which studied more than 17,000 adults with overweight or obesity:
Semaglutide reduced all-cause mortality.
And part of that reduction?
Fewer infection-related deaths.
A meta-analysis of 21 trials on semaglutide and other GLP-1 drugs found:
👉 About a 10% reduction in infections.
If ongoing trials like SURPASS-CVOT confirm similar findings, it strengthens the case that reducing obesity can directly reduce infection mortality.
That moves this from “association” to “probably causal.”
Two Weird Exceptions
Interestingly, obesity did not increase risk for:
- HIV
- Tuberculosis
Why?
Likely reverse causality.
Both HIV and TB often cause wasting and weight loss.
In those cases, being underweight can be more dangerous than being overweight.
So the relationship flips.
Context matters.
What About Weight Change?
Here’s some hopeful news.
In repeat measurements:
- Gaining weight increased infection risk.
- Losing weight from obesity modestly reduced infection risk.
Not dramatic.
But directionally consistent.
The immune system seems to improve when excess adiposity decreases.
Important Caveats (Because Science)
This was observational research.
That means:
- It can’t prove cause and effect.
- BMI isn’t a perfect measure of body fat.
- Some data relied on electronic health records.
- Global estimates are imperfect.
But the findings were consistent across:
- Different countries
- Different obesity measures
- Different infection types
- Different subgroups
The signal is strong.
The Bigger Reframe
We tend to think of obesity as a chronic disease issue.
This study suggests it’s also a communicable disease amplifier.
It doesn’t just increase your risk of:
- Diabetes
- Heart disease
- Cancer
It may also increase your risk of:
- Severe pneumonia
- Serious bacterial infections
- Complicated viral infections
Obesity may not cause the infection.
But it may make the infection hit harder.
The Public Health Takeaway
If obesity prevention reduced global adiposity levels meaningfully, researchers estimate:
👉 Up to 1 in 10 infection-related deaths could potentially be prevented.
That puts obesity prevention in the same conversation as:
- Vaccination strategies
- Antibiotic stewardship
- Pandemic preparedness
That’s a bigger frame than we usually give it.
The Bottom Line
Obesity isn’t just about long-term chronic disease risk.
It appears to:
- Weaken immune defenses
- Increase infection severity
- Raise hospitalisation risk
- Contribute to global infection mortality
In other words:
It doesn’t just affect how long you live.
It may affect how well you survive when something infectious shows up.
And that changes the stakes.
Nyberg ST, Frank P, Ahmadi-Abhari S, Pentti J, Vahtera J, Ervasti J, Suominen SB, Strandberg TE, Sipilä PN, Meri S, Sattar N, Kivimäki M. Adult obesity and risk of severe infections: a multicohort study with global burden estimates. Lancet. 2026 Feb 9:S0140-6736(25)02474-2. doi: 10.1016/S0140-6736(25)02474-2. Epub ahead of print. PMID: 41679324.
